Developer docs
API playgroundTry for free, no card

Search company profiles

Sophion Bioscience

Full company profile

uuid000gfo1

Namestring
Sophion Bioscience
Legal namestring
Sophion Bioscience A/S
Websiteurl
sophion.com
Company typeenum
Private
Founded yearint
2000
Descriptiontext

Sophion Bioscience is a Danish life-science instrumentation company founded in 2000 that develops and manufactures automated patch clamp (APC) systems used in ion channel research and drug discovery. Its core product portfolio spans three hardware platforms — QPatch Compact for academic and detailed ion channel characterization, QPatch for medicinal chemistry and primary screening, and the high-throughput Qube 384 (384-well) for large-scale screening campaigns — supplemented by proprietary consumables (QPlates, QChips), add-on modules (optogenetics, temperature control, Sophion Hive data management, stacker), validated cell lines and Ringer's solutions, and a new organ-on-a-chip product called Ethica M for cardiac and muscle contractility assays.

The company monetizes through a mix of capital equipment sales, recurring consumables tied to the installed base, multi-year service and support contracts, and a Technology Access Program that lets researchers use Sophion's platforms and expertise. Go-to-market combines direct enterprise field sales out of Denmark, the US, Japan, and China with distribution partners in Korea (IWOO Scientific) and India (Marsap Services), supplemented by a scientific community-building program anchored on the Ion Channel Modulation Symposium (ICMS) and the Sophion Academy training and grants platform.

Sophion sells primarily to pharmaceutical and biotech companies, contract research organizations (including Charles River, Evotec, Metrion Biosciences, and B'SYS), and academic institutions, with secondary verticals in agrochemical, food and beverage, and cosmetics safety testing. The company is privately held, ISO 9001:2015 certified, operates with 101-250 employees, and maintains wholly-owned subsidiaries in the US, Japan, and China alongside its Ballerup, Denmark headquarters. No venture or private equity funding rounds, acquisitions, or parent company relationships were disclosed.

Short descriptiontext

Sophion Bioscience is a Danish privately-held life-science instrumentation company that designs and manufactures automated patch clamp systems, proprietary consumables, and organ-on-a-chip products for ion channel research and drug discovery, serving pharmaceutical companies, CROs, and academic institutions globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBallerup, Denmark
HQ citystring
Ballerup
HQ countrystring
Denmark
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
automated patch clamp, ion channel research, electrophysiology instrumentation, drug discovery platforms, laboratory automation systems
Industry1 code
PRIMARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code1 code
  • Analytical Laboratory Instrument Manufacturing334516
SIC code1 code
  • Laboratory Analytical Instruments3826
Product category
Scientific Laboratory Instruments (Automated Patch Clamp)
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1Automated Patch Clamp Instruments
TypeHardware Sales
Description

Sale of hardware instruments including QPatch Compact, QPatch, and Qube 384 platforms. These are precision scientific instruments sold to pharmaceutical companies, CROs, and academic institutions for ion channel research.

sophion.com
2Consumables
TypeHardware Sales
Description

Ongoing sales of consumables including QPlates and QChips that are used with the automated patch clamp instruments. Creates recurring revenue stream from installed customer base.

sophion.com
3Service & Support Plans
TypeSubscription Recurring
Description

Technical support, application support, and service contracts to ensure maximum instrument uptime and customer productivity.

sophion.com
4Technology Access Program
TypeProfessional Services
Description

Program allowing researchers to access Sophion's platforms and expertise in their labs, providing flexible engagement options for customers.

sophion.com
5Cell Lines and Ringer's Solutions
TypeHardware Sales
Description

Validated and optimized cell lines and solutions for use across Sophion's automated patch clamp platforms.

sophion.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Operations, Personnel, Marketing or Sales, Infrastructure, Supply Chain
Pricing details1 tier
1Enterprise/Custom Pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based pricing for automated patch clamp instruments and service contracts. Pricing varies based on platform configuration, throughput requirements, and service level selection.

sophion.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1ICMS (Ion Channel Modulation Symposium)
Description

Annual international symposium series organized by Sophion Bioscience bringing together researchers from academia, CROs, and pharmaceutical industry to discuss ion channel modulation research

sophion.com
Core offering1 text field

Sophion Bioscience designs, manufactures, and sells automated patch clamp (APC) instrumentation, consumables, biological reagents, and supporting software and services for ion channel research and drug discovery. Its core offerings are the QPatch Compact, QPatch, and Qube 384 APC platforms, the Ethica M organ-on-a-chip contractility system, proprietary QPlates and QChips consumables, validated cell lines and Ringer's solutions, the Sophion Hive data management platform, and service & support plans plus a Technology Access Program for laboratory customers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Researchers can test 8 compounds on 3 ion channels with full dose responses in one day, compared to testing 1 compound on 1 ion channel with manual patch clamp
+1 more record
Product overview1 text field

Sophion Bioscience offers a complete automated patch clamp solution portfolio for ion channel research and drug discovery. The core platform lineup includes QPatch Compact and QPatch (manual-to-automated systems for academic research and primary screening) and Qube 384 (high-throughput system for large screening campaigns). These platforms are complemented by proprietary consumables (QPlates, QChips), add-on modules (QPC Opto 465 for optogenetics, QPrep, Sophion Hive, Temperature Control, Adaptive Current Clamp, Rs Compensation, Qube 384 Stacker, Virtual Qube), and biological consumables (validated cell lines and Ringer's solutions). The company also offers Ethica M, an organ-on-a-chip contractility solution for replicating human heart and muscle function. Full customer services include service & support plans and a Technology Access Program.

Product and service10 records
1QPatch Compact
CategoryAutomated Patch Clamp Instruments
Description

Automated patch clamp (APC) instrument designed for academic research and detailed ion channel characterization, delivering faster, more accurate and objective patch clamp results independent of user skill. Sold to academic institutions, pharmaceutical companies, and CROs.

2QPatch
CategoryAutomated Patch Clamp Instruments
Description

Automated patch clamp platform for medicinal chemistry iteration and primary screening, enabling faster turnaround of electrophysiology data for drug discovery programs. Targeted at pharmaceutical and CRO customers running compound screening.

3Qube 384
CategoryAutomated Patch Clamp Instruments
Description

High-throughput automated patch clamp platform with 384-well capacity, designed for maximum throughput and efficiency in large-scale ion channel screening campaigns; supports unattended overnight operation. Sold to pharmaceutical companies, CROs, and academic core facilities running high-volume screening.

4Ethica M
CategoryOrgan-on-a-Chip Instruments
Description

Organ-on-a-chip contractility solution that replicates human heart and muscle function with high throughput, providing faster, more ethical drug discovery with better predictions and lower costs. Sold to pharmaceutical, CRO and academic researchers in cardiac and muscle safety research.

5QPlates
CategoryConsumables
Description

Proprietary plate consumables designed for use with Sophion automated patch clamp systems, sold as ongoing consumables to customers with installed QPatch instruments.

6QChips
CategoryConsumables
Description

Chip consumables for the Qube 384 platform, usable in full or partial configurations (starting from 96 wells, scaling in 32-well increments) to optimize consumable usage and reduce waste. Sold as recurring consumables to Qube 384 customers.

7Cell Lines
CategoryBiological Consumables
Description

Validated and optimized cell lines for use across Sophion automated patch clamp platforms, providing consistent and reproducible results for ion channel research. Sold to instrument customers as a recurring biological consumable.

8Ringer's Solutions
CategoryBiological Consumables
Description

Ringer's solutions validated and optimized for use across Sophion automated patch clamp platforms, providing best results in ion channel recordings. Sold as a recurring consumable to instrument customers.

9Sophion Service & Support Plans
CategoryService Plans
Description

Comprehensive technical and application service plans offering fast response times, application support, and maximum instrument uptime to support laboratory productivity for Sophion customers. Sold via multi-year service contracts to the installed base.

10Technology Access Program
CategoryProfessional Services
Description

Program providing researchers access to Sophion's automated patch clamp platforms and technical expertise in Sophion's laboratories, enabling flexible engagement and evaluation without capital purchase. Sold as a services engagement to pharmaceutical, CRO and academic researchers.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
1IWOO Scientific
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

IWOO Scientific Corporation is Sophion's authorized distributor in South Korea, providing local sales, support, and service for Sophion's automated patch clamp solutions to Korean customers. Located at 5F, 30, Banpo-daero 23-gil, Seocho-gu, Seoul 06656.

sophion.com
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Marsap Services Pvt. Ltd. is Sophion's authorized distributor in India, providing local sales, support, and service for Sophion's automated patch clamp solutions to Indian customers. Located at 29, Ujagar Industrial Estate, W.T.P. Marg, Deonar, Mumbai.

Strategic tierStrategicTypeTechnology or Integration
Description

CytoCybernetics collaborated with Sophion on a webinar demonstrating integration of Sophion's QPatch automated patch clamp data with CytoCybernetics' CyberQ-qNet workflow for CiPA-based in silico cardiac safety evaluation. Dr. Randall Rasmusson from CytoCybernetics presented alongside Sophion's Dr. Patric Vaelli.

4Boehringer Ingelheim
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Boehringer Ingelheim is connected to Sophion through Dr. Nadia von Schoubye's lab, which is supporting Nikolaos Oikonomopoulos' research grant at Sophion's Copenhagen labs focused on primary neuron APC assays for drug discovery.

sophion.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Ulm University in Germany is the academic institution of Nikolaos Oikonomopoulos, who is conducting research on primary neuron APC assays at Sophion's Copenhagen labs through a research grant, bridging academia and industry.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

Direct competitor in automated patch clamp with the IonWorks and PatchXpress platforms. Now part of Danaher, Molecular Devices sells a broader portfolio of life science instruments and benefits from greater scale and bundling leverage than Sophion.

TypeDirect peer
Description

Provides the Maestro multi-electrode array (MEA) platform for electrophysiology and cardiac safety. Axion competes with Sophion for preclinical cardiac safety and neuroscience screening budgets.

TypeEmerging player
Description

Swiss-based developer of high-density CMOS-MEA chips for neuronal recording and drug discovery. MaxWell targets overlapping pharma/neuroscience screening budgets with a complementary (not directly substitutable) technology to Sophion's APC.

TypeDirect peer
Description

Germany-based direct competitor in automated patch clamp with Port-a-Patch, Patchliner, and SyncroPatch 384i. Nanion competes head-to-head with Sophion across academic, CRO, and pharma segments for ion channel screening instruments.

TypeDirect peer
Description

Long-established manufacturer of patch clamp and electrophysiology amplifiers (EPC series). HEKA competes with Sophion in the academic and detailed ion channel characterization segments, particularly for manual-to-automated workflows.

TypeEmerging player
Description

Provides the CyberQ-qNet in silico cardiac safety evaluation workflow that integrates with Sophion's QPatch for CiPA-based assessment. A technology integration partner rather than head-to-head competitor, but addresses the same cardiac safety procurement budget.

TypeDirect peer
Description

Provides MEA and electrophysiology recording systems for cardiac and neuroscience screening. MCS overlaps with Sophion in cardiac safety profiling and academic ion channel research applications.

8Fluxion Biosciences
TypeDirect peer
Description

Direct competitor offering the IonFlux automated patch clamp platform for ion channel research. Fluxion targets similar pharma, CRO, and academic customers with a differentiated well-plate-based APC architecture.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sophion Bioscience

Scientific Laboratory Instruments (Automated Patch Clamp)sophion.com

Sophion Bioscience is a Danish privately-held life-science instrumentation company that designs and manufactures automated patch clamp systems, proprietary consumables, and organ-on-a-chip products for ion channel research and drug discovery, serving pharmaceutical companies, CROs, and academic institutions globally.

What Sophion Bioscience does

Sophion Bioscience is a Danish life-science instrumentation company founded in 2000 that develops and manufactures automated patch clamp (APC) systems used in ion channel research and drug discovery. Its core product portfolio spans three hardware platforms — QPatch Compact for academic and detailed ion channel characterization, QPatch for medicinal chemistry and primary screening, and the high-throughput Qube 384 (384-well) for large-scale screening campaigns — supplemented by proprietary consumables (QPlates, QChips), add-on modules (optogenetics, temperature control, Sophion Hive data management, stacker), validated cell lines and Ringer's solutions, and a new organ-on-a-chip product called Ethica M for cardiac and muscle contractility assays.

The company monetizes through a mix of capital equipment sales, recurring consumables tied to the installed base, multi-year service and support contracts, and a Technology Access Program that lets researchers use Sophion's platforms and expertise. Go-to-market combines direct enterprise field sales out of Denmark, the US, Japan, and China with distribution partners in Korea (IWOO Scientific) and India (Marsap Services), supplemented by a scientific community-building program anchored on the Ion Channel Modulation Symposium (ICMS) and the Sophion Academy training and grants platform.

Sophion sells primarily to pharmaceutical and biotech companies, contract research organizations (including Charles River, Evotec, Metrion Biosciences, and B'SYS), and academic institutions, with secondary verticals in agrochemical, food and beverage, and cosmetics safety testing. The company is privately held, ISO 9001:2015 certified, operates with 101-250 employees, and maintains wholly-owned subsidiaries in the US, Japan, and China alongside its Ballerup, Denmark headquarters. No venture or private equity funding rounds, acquisitions, or parent company relationships were disclosed.

Sophion Bioscience firmographics

Firmographics
Name
Sophion Bioscience
Legal name
Sophion Bioscience A/S
Website
https://sophion.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
101–250 employees
Short description
Sophion Bioscience is a Danish privately-held life-science instrumentation company that designs and manufactures automated patch clamp systems, proprietary consumables, and organ-on-a-chip products for ion channel research and drug discovery, serving pharmaceutical companies, CROs, and academic institutions globally.
Ownership category
akta.pro rank

Sophion Bioscience industry classification

Industry
Product category
Scientific Laboratory Instruments (Automated Patch Clamp)
NAICS
Analytical Laboratory Instrument Manufacturing (334516)
SIC
Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Automated patch clamp
  • Ion channel research
  • Electrophysiology instrumentation
  • Drug discovery platforms
  • Laboratory automation systems

Where Sophion Bioscience is headquartered

Location

Headquarters

HQ city
Ballerup
HQ country
Denmark
HQ region
Europe

Offices4 records

Markets served

Sophion Bioscience business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Operations, Personnel, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. Automated Patch Clamp Instruments: Sale of hardware instruments including QPatch Compact, QPatch, and Qube 384 platforms. These are precision scientific instruments sold to pharmaceutical companies, CROs, and academic institutions for ion channel research.
  2. Consumables: Ongoing sales of consumables including QPlates and QChips that are used with the automated patch clamp instruments. Creates recurring revenue stream from installed customer base.
  3. Service & Support Plans: Technical support, application support, and service contracts to ensure maximum instrument uptime and customer productivity.
  4. Technology Access Program: Program allowing researchers to access Sophion's platforms and expertise in their labs, providing flexible engagement options for customers.
  5. Cell Lines and Ringer's Solutions: Validated and optimized cell lines and solutions for use across Sophion's automated patch clamp platforms.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEnterprise/Custom Pricing

Go-to-market motion3 records

Distribution channels2 records

Marketing channels7 records

Sophion Bioscience product offering

Product offering

Core offering

Sophion Bioscience designs, manufactures, and sells automated patch clamp (APC) instrumentation, consumables, biological reagents, and supporting software and services for ion channel research and drug discovery. Its core offerings are the QPatch Compact, QPatch, and Qube 384 APC platforms, the Ethica M organ-on-a-chip contractility system, proprietary QPlates and QChips consumables, validated cell lines and Ringer's solutions, the Sophion Hive data management platform, and service & support plans plus a Technology Access Program for laboratory customers.

Product overview

Sophion Bioscience offers a complete automated patch clamp solution portfolio for ion channel research and drug discovery. The core platform lineup includes QPatch Compact and QPatch (manual-to-automated systems for academic research and primary screening) and Qube 384 (high-throughput system for large screening campaigns). These platforms are complemented by proprietary consumables (QPlates, QChips), add-on modules (QPC Opto 465 for optogenetics, QPrep, Sophion Hive, Temperature Control, Adaptive Current Clamp, Rs Compensation, Qube 384 Stacker, Virtual Qube), and biological consumables (validated cell lines and Ringer's solutions). The company also offers Ethica M, an organ-on-a-chip contractility solution for replicating human heart and muscle function. Full customer services include service & support plans and a Technology Access Program.

Differentiator

Problem solved

Functional benefit

Brands

  • ICMS (Ion Channel Modulation Symposium): Annual international symposium series organized by Sophion Bioscience bringing together researchers from academia, CROs, and pharmaceutical industry to discuss ion channel modulation research

Products and services

  • QPatch Compact Automated patch clamp (APC) instrument designed for academic research and detailed ion channel characterization, delivering faster, more accurate and objective patch clamp results independent of user skill. Sold to academic institutions, pharmaceutical companies, and CROs.
  • QPatch Automated patch clamp platform for medicinal chemistry iteration and primary screening, enabling faster turnaround of electrophysiology data for drug discovery programs. Targeted at pharmaceutical and CRO customers running compound screening.
  • Qube 384 High-throughput automated patch clamp platform with 384-well capacity, designed for maximum throughput and efficiency in large-scale ion channel screening campaigns; supports unattended overnight operation. Sold to pharmaceutical companies, CROs, and academic core facilities running high-volume screening.
  • Ethica M Organ-on-a-chip contractility solution that replicates human heart and muscle function with high throughput, providing faster, more ethical drug discovery with better predictions and lower costs. Sold to pharmaceutical, CRO and academic researchers in cardiac and muscle safety research.
  • QPlates Proprietary plate consumables designed for use with Sophion automated patch clamp systems, sold as ongoing consumables to customers with installed QPatch instruments.
  • QChips Chip consumables for the Qube 384 platform, usable in full or partial configurations (starting from 96 wells, scaling in 32-well increments) to optimize consumable usage and reduce waste. Sold as recurring consumables to Qube 384 customers.
  • Cell Lines Validated and optimized cell lines for use across Sophion automated patch clamp platforms, providing consistent and reproducible results for ion channel research. Sold to instrument customers as a recurring biological consumable.
  • Ringer's Solutions Ringer's solutions validated and optimized for use across Sophion automated patch clamp platforms, providing best results in ion channel recordings. Sold as a recurring consumable to instrument customers.
  • Sophion Service & Support Plans Comprehensive technical and application service plans offering fast response times, application support, and maximum instrument uptime to support laboratory productivity for Sophion customers. Sold via multi-year service contracts to the installed base.
  • Technology Access Program Program providing researchers access to Sophion's automated patch clamp platforms and technical expertise in Sophion's laboratories, enabling flexible engagement and evaluation without capital purchase. Sold as a services engagement to pharmaceutical, CRO and academic researchers.

Quantifiable outcome

  • Researchers can test 8 compounds on 3 ion channels with full dose responses in one day, compared to testing 1 compound on 1 ion channel with manual patch clamp
  • +1 more outcomes

Companies that use Sophion Bioscience

Customer profile

Named customers7 records

Segments6 records

Ideal customer profiles3 records

Sophion Bioscience technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature10 records

Sophion Bioscience partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core, strategic and minor.

  • IWOO ScientificcoreChannel Partner/ Reseller/ DistributorIWOO Scientific Corporation is Sophion's authorized distributor in South Korea, providing local sales, support, and service for Sophion's automated patch clamp solutions to Korean customers. Located at 5F, 30, Banpo-daero 23-gil, Seocho-gu, Seoul 06656.
  • Marsap ServicescoreChannel Partner/ Reseller/ DistributorMarsap Services Pvt. Ltd. is Sophion's authorized distributor in India, providing local sales, support, and service for Sophion's automated patch clamp solutions to Indian customers. Located at 29, Ujagar Industrial Estate, W.T.P. Marg, Deonar, Mumbai.
  • CytoCyberneticsstrategicTechnology or IntegrationCytoCybernetics collaborated with Sophion on a webinar demonstrating integration of Sophion's QPatch automated patch clamp data with CytoCybernetics' CyberQ-qNet workflow for CiPA-based in silico cardiac safety evaluation. Dr. Randall Rasmusson from CytoCybernetics presented alongside Sophion's Dr. Patric Vaelli.
  • Boehringer IngelheimminorStrategic or Co-development PartnerBoehringer Ingelheim is connected to Sophion through Dr. Nadia von Schoubye's lab, which is supporting Nikolaos Oikonomopoulos' research grant at Sophion's Copenhagen labs focused on primary neuron APC assays for drug discovery.
  • Ulm UniversityminorStrategic or Co-development PartnerUlm University in Germany is the academic institution of Nikolaos Oikonomopoulos, who is conducting research on primary neuron APC assays at Sophion's Copenhagen labs through a research grant, bridging academia and industry.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Sophion Bioscience competitors and assessment

Company assessment

Direct peers

  • Molecular Devices: Direct competitor in automated patch clamp with the IonWorks and PatchXpress platforms. Now part of Danaher, Molecular Devices sells a broader portfolio of life science instruments and benefits from greater scale and bundling leverage than Sophion.
  • Axion Biosystems: Provides the Maestro multi-electrode array (MEA) platform for electrophysiology and cardiac safety. Axion competes with Sophion for preclinical cardiac safety and neuroscience screening budgets.
  • Nanion Technologies: Germany-based direct competitor in automated patch clamp with Port-a-Patch, Patchliner, and SyncroPatch 384i. Nanion competes head-to-head with Sophion across academic, CRO, and pharma segments for ion channel screening instruments.
  • HEKA Elektronik (Harvard Bioscience): Long-established manufacturer of patch clamp and electrophysiology amplifiers (EPC series). HEKA competes with Sophion in the academic and detailed ion channel characterization segments, particularly for manual-to-automated workflows.
  • Multi Channel Systems (Harvard Bioscience): Provides MEA and electrophysiology recording systems for cardiac and neuroscience screening. MCS overlaps with Sophion in cardiac safety profiling and academic ion channel research applications.
  • Fluxion Biosciences: Direct competitor offering the IonFlux automated patch clamp platform for ion channel research. Fluxion targets similar pharma, CRO, and academic customers with a differentiated well-plate-based APC architecture.

Emerging players

  • MaxWell Biosystems: Swiss-based developer of high-density CMOS-MEA chips for neuronal recording and drug discovery. MaxWell targets overlapping pharma/neuroscience screening budgets with a complementary (not directly substitutable) technology to Sophion's APC.
  • CytoCybernetics: Provides the CyberQ-qNet in silico cardiac safety evaluation workflow that integrates with Sophion's QPatch for CiPA-based assessment. A technology integration partner rather than head-to-head competitor, but addresses the same cardiac safety procurement budget.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Sophion Bioscience social profiles

Digital presence

Sophion Bioscience compliance and trust

Trust signal

Compliance1 record

Sophion Bioscience financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sophion Bioscience leadership team

Management profile

Number of profiles

Profiles12 records

Sophion Bioscience subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Sophion Bioscience funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sophion Bioscience M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sophion Bioscience

What does Sophion Bioscience do?

Sophion Bioscience designs, manufactures, and sells automated patch clamp (APC) instrumentation, consumables, biological reagents, and supporting software and services for ion channel research and drug discovery. Its core offerings are the QPatch Compact, QPatch, and Qube 384 APC platforms, the Ethica M organ-on-a-chip contractility system, proprietary QPlates and QChips consumables, validated cell lines and Ringer's solutions, the Sophion Hive data management platform, and service & support plans plus a Technology Access Program for laboratory customers.

Is Sophion Bioscience a public or private company?

Sophion Bioscience is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Sophion Bioscience founded?

Sophion Bioscience was founded in 2000. It employs 101 to 250 people.

Where is Sophion Bioscience based?

Sophion Bioscience is headquartered in Ballerup, Denmark, in the Europe region.

How does Sophion Bioscience make money?

Five revenue lines are on record. Automated Patch Clamp Instruments are the primary driver. The others are consumables, service & Support Plans, technology Access Program and cell Lines and Ringer's Solutions.

Who are Sophion Bioscience's main competitors?

Direct peers on record are Molecular Devices, Axion Biosystems, Nanion Technologies, HEKA Elektronik (Harvard Bioscience), Multi Channel Systems (Harvard Bioscience) and Fluxion Biosciences. Emerging players are MaxWell Biosystems and CytoCybernetics.

Does Sophion Bioscience have an API?

No public API is recorded for Sophion Bioscience.

What industry is Sophion Bioscience in?

Sophion Bioscience's product category is Scientific Laboratory Instruments (Automated Patch Clamp). Its primary akta.pro industry code is HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization. Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales